Ulcerative Colitis (UC)

Also known as: Colitis Ulcerative / Colitis,Ulcerative / Ulcerative Colitis / Colitis, Ulcerative / Proctocolitis, idiopathic / Idiopathic proctocolitis / UC / Ulcerative colitis, unspecified

DrugDrug NameDrug Description
DB00443BetamethasoneA glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
DB01222BudesonideBudesonide is a glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis. [PubChem] The extended release oral tablet, marketed as Uceris, was FDA approved on January 14, 2013 for the management of ulcerative colitis. Budesonide is provided as a mixture of two epimers (22R and 22S). Interestingly, the 22R form is two times more active than the 22S epimer. The two forms do not interconvert.
DB00297BupivacaineA widely used local anesthetic agent. [PubChem]
DB01380Cortisone acetateCortisone acetate is a steroid hormone that has both glucocoriticoid and mineral corticoid activities. Corticosteroids are used to provide relief for inflamed areas of the body. They lessen swelling, redness, itching, and allergic reactions. They are often used as part of the treatment for a number of different diseases, such as severe allergies or skin problems, asthma, or arthritis. Endogenous glucocorticoids and some synthetic corticoids have high affinity to the protein transcortin (also called CBG, corticosteroid-binding protein), whereas all of them bind albumin. Glucocorticoids also bind to the cytosolic glucocorticoid receptor.
DB01234DexamethasoneAn anti-inflammatory 9-fluoro-glucocorticoid.
DB00741HydrocortisoneThe main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.
DB14539Hydrocortisone acetateNot Available
DB00065InfliximabInfliximab is a tumor necrosis factor (TNF-alpha or TNF-α) blocker and a chimeric monoclonal IgG1 antibody composed of human constant (75%) and murine variable (25%) regions [A31469]. Infliximab is produced by a recombinant cell line cultured by continuous perfusion. Tumor necrosis factor-alpha (TNF-α) is a key proinflammatory cytokine involved in chronic inflammatory diseases [A31469]. Its hyperactivity and enhanced signalling pathways can be observed in inflammatory diseases where it activates further pro-inflammatory cascades. By binding to both the soluble subunit and the membrane-bound precursor of TNF-α [A106], infliximab disrupts the interaction of TNF-α with its receptors and may also cause lysis of cells that produce TNF-α [A106]. Infliximab was first approved by the FDA in 1998 under the market name Remicade as an intravenous injection. It is indicated for the treatment of various inflammatory disorders such as adult or pediatric Chron's disease, adult or pediatric ulcerative colitis, rheumatoid arthritis in combination with methotrexate, ankylosing spondyliti, psoriatic arthritis, and plaque psoriasis [FDA Label]. In clinical trials, multiple infusions of infliximab displayed in a reduction of signs and symptoms of inflammatory diseases and induction of remission in patients who have had an inadequate response to alternative first-line therapies for that disorder [FDA Label]. There are currently two biosilimars of infliximab available in the US market that demonstrate a high degree of similarity to the reference product, Remicade. They are approved for all eligible indications of the reference product. Inflectra, a first biosimilar drug product, was approved in 2016. In December 2017, Ixifi, a second biosimilar that was developed by Pfizer, was granted approval by the FDA.
DB01033MercaptopurineAn antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. [PubChem]
DB00244MesalazineAn anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease [A174022]. It is considered to be the active moiety of sulphasalazine. (From Martindale, The Extra Pharmacopoeia, 30th ed) Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stability as a pharmaceutical agent [A174019]. Throughout the late seventies and the eighties, important research initiatives developed stable mesalazine formulations like the eudragit-S coating of Asacol brand mesalazine and the Pentasa brand's encapsulation of mesalazine within microgranules [A174019]. In the present day, contemporary research regarding novel methods to stabilize mesalazine continues and interest in the agent's capacity to decrease inflammatory activity and subsequently potentially reduce the risk of colorectal cancer in conditions like ulcerative colitis is maintained [A174019, A174022].
DB00959MethylprednisoloneA prednisolone derivative with similar anti-inflammatory action.
DB01250OlsalazineOlsalazine is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. Olsalazine is a derivative of salicylic acid. Inactive by itself (it is a prodrug), it is converted by the bacteria in the colon to mesalamine. Mesalamine works as an anti-inflammatory agent in treating inflammatory diseases of the intestines.
DB00860PrednisoloneA glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
DB00635PrednisoneA synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver.
DB01284TetracosactideTetracosactide (also known as Cosyntropin) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. Tetracosactide exhibits the same activity as natural ACTH with regard to all its biological activities. The complex results in a product whose absorption in man is effected over a longer period of time as compared to corticotropin. Therefore, therapy may be maintained with less frequent administration.
DB00620TriamcinoloneA glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)
DrugDrug NameTargetType
DB00443BetamethasoneGlucocorticoid receptortarget
DB00443BetamethasoneCytochrome P450 3A4enzyme
DB00443BetamethasoneMultidrug resistance protein 1transporter
DB00443BetamethasoneCytochrome P450 19A1enzyme
DB01222BudesonideGlucocorticoid receptortarget
DB01222BudesonideCytochrome P450 3A4enzyme
DB01222BudesonideCytochrome P450 3A5enzyme
DB01222BudesonideBile salt export pumptransporter
DB00297BupivacaineSodium channel protein type 10 subunit alphatarget
DB00297BupivacaineProstaglandin E2 receptor EP1 subtypetarget
DB00297BupivacaineCytochrome P450 3A4enzyme
DB00297BupivacaineCytochrome P450 2C19enzyme
DB00297BupivacaineCytochrome P450 2D6enzyme
DB01380Cortisone acetateGlucocorticoid receptortarget
DB01380Cortisone acetateCytochrome P450 3A4enzyme
DB01234DexamethasoneGlucocorticoid receptortarget
DB01234DexamethasoneAnnexin A1target
DB01234DexamethasoneNitric oxide synthase, inducibletarget
DB01234DexamethasoneNuclear receptor subfamily 0 group B member 1target
DB01234DexamethasoneCytochrome P450 3A4enzyme
DB01234DexamethasoneCytochrome P450 3A5enzyme
DB01234DexamethasoneCytochrome P450 3A7enzyme
DB01234DexamethasoneBile salt export pumptransporter
DB01234DexamethasoneMultidrug resistance protein 1transporter
DB01234DexamethasoneCanalicular multispecific organic anion transporter 1transporter
DB01234DexamethasoneSolute carrier organic anion transporter family member 1A2transporter
DB01234DexamethasoneATP-binding cassette sub-family G member 2transporter
DB01234DexamethasoneCholesterol side-chain cleavage enzyme, mitochondrialenzyme
DB01234DexamethasoneSteroid 17-alpha-hydroxylase/17,20 lyaseenzyme
DB01234DexamethasoneCytochrome P450 19A1enzyme
DB01234DexamethasoneCytochrome P450 1A1enzyme
DB01234DexamethasoneCytochrome P450 1B1enzyme
DB01234DexamethasoneCytochrome P450 2A6enzyme
DB01234DexamethasoneCytochrome P450 2B6enzyme
DB01234DexamethasoneCytochrome P450 2C19enzyme
DB01234DexamethasoneCytochrome P450 2C8enzyme
DB01234DexamethasoneCytochrome P450 2D6enzyme
DB01234DexamethasoneCytochrome P450 2E1enzyme
DB01234DexamethasoneCytochrome P450 3A43enzyme
DB01234DexamethasoneCytochrome P450 4A11enzyme
DB01234DexamethasoneNuclear receptor subfamily 1 group I member 2target
DB00741HydrocortisoneAnnexin A1target
DB00741HydrocortisoneGlucocorticoid receptortarget
DB00741HydrocortisoneSex hormone-binding globulincarrier
DB00741HydrocortisoneCytochrome P450 3A4enzyme
DB00741HydrocortisoneCytochrome P450 3A5enzyme
DB00741HydrocortisoneCytochrome P450 3A7enzyme
DB00741HydrocortisoneMultidrug resistance protein 1transporter
DB00741HydrocortisoneSolute carrier organic anion transporter family member 1A2transporter
DB00741HydrocortisoneATP-binding cassette sub-family G member 2transporter
DB00741HydrocortisoneCytochrome P450 11B1, mitochondrialenzyme
DB00741HydrocortisoneCytochrome P450 11B2, mitochondrialenzyme
DB00741HydrocortisoneCytochrome P450 2C8enzyme
DB00741HydrocortisoneCorticosteroid-binding globulincarrier
DB00741HydrocortisoneCorticosteroid 11-beta-dehydrogenase isozyme 2target
DB00741Hydrocortisone3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1target
DB00741HydrocortisoneSolute carrier family 22 member 8transporter
DB14539Hydrocortisone acetateAnnexin A1target
DB14539Hydrocortisone acetateGlucocorticoid receptortarget
DB14539Hydrocortisone acetateSex hormone-binding globulincarrier
DB14539Hydrocortisone acetateCytochrome P450 3A4enzyme
DB14539Hydrocortisone acetateCytochrome P450 3A5enzyme
DB14539Hydrocortisone acetateCytochrome P450 3A7enzyme
DB14539Hydrocortisone acetateMultidrug resistance protein 1transporter
DB14539Hydrocortisone acetateSolute carrier organic anion transporter family member 1A2transporter
DB14539Hydrocortisone acetateATP-binding cassette sub-family G member 2transporter
DB14539Hydrocortisone acetateCytochrome P450 11B1, mitochondrialenzyme
DB14539Hydrocortisone acetateCytochrome P450 11B2, mitochondrialenzyme
DB14539Hydrocortisone acetateCytochrome P450 2C8enzyme
DB14539Hydrocortisone acetateCorticosteroid-binding globulincarrier
DB14539Hydrocortisone acetateCorticosteroid 11-beta-dehydrogenase isozyme 2target
DB14539Hydrocortisone acetate3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1target
DB14539Hydrocortisone acetateSolute carrier family 22 member 8transporter
DB00065InfliximabTumor necrosis factortarget
DB01033MercaptopurineThiopurine S-methyltransferaseenzyme
DB01033MercaptopurineXanthine dehydrogenase/oxidaseenzyme
DB01033MercaptopurineHypoxanthine-guanine phosphoribosyltransferasetarget
DB01033MercaptopurineSolute carrier family 22 member 8transporter
DB01033MercaptopurineMultidrug resistance-associated protein 4transporter
DB01033MercaptopurineMultidrug resistance-associated protein 5transporter
DB01033MercaptopurineSodium/nucleoside cotransporter 2transporter
DB01033MercaptopurineSolute carrier family 28 member 3transporter
DB01033MercaptopurineEquilibrative nucleoside transporter 1transporter
DB01033MercaptopurineEquilibrative nucleoside transporter 2transporter
DB01033MercaptopurineAldehyde oxidaseenzyme
DB01033MercaptopurineAmidophosphoribosyltransferasetarget
DB01033MercaptopurineInosine-5'-monophosphate dehydrogenasetarget
DB00244MesalazineProstaglandin G/H synthase 1target
DB00244MesalazineProstaglandin G/H synthase 2target
DB00244MesalazinePeroxisome proliferator-activated receptor gammatarget
DB00244MesalazineInhibitor of nuclear factor kappa-B kinase subunit alphatarget
DB00244MesalazineInhibitor of nuclear factor kappa-B kinase subunit betatarget
DB00244MesalazineArachidonate 5-lipoxygenasetarget
DB00244MesalazineMyeloperoxidasetarget
DB00244MesalazineArylamine N-acetyltransferasetarget
DB00244MesalazineArylamine N-acetyltransferase 1enzyme
DB00959MethylprednisoloneGlucocorticoid receptortarget
DB00959MethylprednisoloneCytochrome P450 3A4enzyme
DB00959MethylprednisoloneMultidrug resistance protein 1transporter
DB01250OlsalazineInterferon gammatarget
DB01250OlsalazineThiopurine S-methyltransferasetarget
DB00860PrednisoloneCorticosteroid-binding globulincarrier
DB00860PrednisoloneCytochrome P450 3A4enzyme
DB00860PrednisoloneGlucocorticoid receptortarget
DB00860PrednisoloneSolute carrier organic anion transporter family member 1A2transporter
DB00860PrednisoloneMultidrug resistance protein 1transporter
DB00635PrednisoneGlucocorticoid receptortarget
DB00635PrednisoneCytochrome P450 3A4enzyme
DB00635PrednisoneMultidrug resistance protein 1transporter
DB00635PrednisoneSolute carrier organic anion transporter family member 1A2transporter
DB00635PrednisoneCytochrome P450 2C19enzyme
DB00635PrednisoneSerum albumincarrier
DB00635PrednisoneCorticosteroid 11-beta-dehydrogenase isozyme 1target
DB01284TetracosactideAdrenocorticotropic hormone receptortarget
DB00620TriamcinoloneCorticosteroid-binding globulincarrier
DB00620TriamcinoloneGlucocorticoid receptortarget
DB00620TriamcinoloneCytochrome P450 3A4enzyme
DB00620TriamcinoloneProstaglandin G/H synthase 2enzyme
DB00620TriamcinoloneCholinesteraseenzyme
DrugDrug NamePhaseStatusCount
DB09033Vedolizumab0Withdrawn1
DB06151Acetylcysteine1Completed1
DB00051Adalimumab1Completed1
DB00855Aminolevulinic acid1Unknown Status1
DB04115Berberine1Active Not Recruiting1
DB11672Curcumin1Completed1
DB06116Eldelumab1Completed1
DB12189Etrolizumab1Recruiting1
DB12296GS-57451Completed2
DB06674Golimumab1Active Not Recruiting1
DB00065Infliximab1Active Not Recruiting1
DB00065Infliximab1Completed1
DB00244Mesalazine1Completed5
DB06396Mesalazine1Completed1
DB00244Mesalazine1Terminated1
DB11057Mineral oil1Completed1
DB09035Nivolumab1Not Yet Recruiting2
DB12186SRT-21041Completed1
DB09033Vedolizumab1Completed1
DB09061Cannabidiol1 / 2Completed1
DB00169Cholecalciferol1 / 2Withdrawn1
DB00257Clotrimazole1 / 2Suspended1
DB00153Ergocalciferol1 / 2Withdrawn1
DB05212HE32861 / 2Completed1
DB00244Mesalazine1 / 2Active Not Recruiting1
DB05914Mesenchymal Stem Cells1 / 2Unknown Status1
DB00075Muromonab1 / 2Completed1
DB06803Niclosamide1 / 2Recruiting1
DB00507Nitazoxanide1 / 2Active Not Recruiting1
DB00338Omeprazole1 / 2Completed1
DB00412Rosiglitazone1 / 2Unknown Status1
DB11094Vitamin D1 / 2Withdrawn1
DB05340ATL-25022Completed1
DB06224Alicaforsen2Completed2
DB00415Ampicillin2Completed1
DB05767Andrographolide2Completed1
DB12294Anrukinzumab2Completed1
DB05676Apremilast2Active Not Recruiting1
DB00074Basiliximab2Completed1
DB00074Basiliximab2Terminated1
DB01222Budesonide2Completed1
DB01222Budesonide2Terminated1
DB09061Cannabidiol2Completed1
DB09310Catridecacog2Terminated1
DB01212Ceftriaxone2Recruiting1
DB08904Certolizumab pegol2Active Not Recruiting1
DB00091Ciclosporin2Recruiting1
DB00111Daclizumab2Completed1
DB06251Dersalazine2Completed1
DB00254Doxycycline2Recruiting1
DB06116Eldelumab2Completed1
DB12135Elubrixin2Terminated1
DB12189Etrolizumab2Completed1
DB06674Golimumab2Completed1
DB06674Golimumab2Recruiting1
DB00060Interferon beta-1a2Completed2
DB12583Maltodextrin2Not Yet Recruiting1
DB00244Mesalazine2Completed2
DB00244Mesalazine2Recruiting2
DB00563Methotrexate2Completed2
DB00916Metronidazole2Recruiting2
DB00704Naltrexone2Withdrawn1
DB12612Ozanimod2Active Not Recruiting1
DB11708Peficitinib2Completed1
DB11656Rebamipide2Completed1
DB00412Rosiglitazone2Completed1
DB08839Serotonin2Recruiting1
DB12095Telotristat ethyl2Completed1
DB00857Terbinafine2Recruiting1
DB05298Tetomilast2Terminated1
DB12166Tetomilast2Terminated1
DB08895Tofacitinib2Completed1
DB12169Tralokinumab2Completed1
DB12346Vatelizumab2Terminated2
DB09033Vedolizumab2Completed2
DB09033Vedolizumab2Recruiting3
DB09033Vedolizumab2Withdrawn1
DB12053Visilizumab2Terminated2
DB00163Vitamin E2Terminated1
DB09145Water2Completed1
DB00898Ethanol2 / 3Recruiting1
DB12296GS-57452 / 3Terminated1
DB06674Golimumab2 / 3Completed1
DB06674Golimumab2 / 3Terminated1
DB00244Mesalazine2 / 3Recruiting1
DB12612Ozanimod2 / 3Not Yet Recruiting1
DB00635Prednisone2 / 3Recruiting1
DB14762Risankizumab2 / 3Recruiting1
DB00073Rituximab2 / 3Completed1
DB14555Ursadiol2 / 3Not Yet Recruiting1
DB01586Ursodeoxycholic acid2 / 3Not Yet Recruiting1
DB12053Visilizumab2 / 3Completed1
DB12053Visilizumab2 / 3Terminated2
DB05340ATL-25023Completed1
DB01281Abatacept3Completed1
DB00051Adalimumab3Active Not Recruiting1
DB00051Adalimumab3Completed7
DB00051Adalimumab3Enrolling by Invitation1
DB00051Adalimumab3Recruiting3
DB00051Adalimumab3Unknown Status1
DB00437Allopurinol3Recruiting1
DB05767Andrographolide3Terminated2
DB00993Azathioprine3Recruiting1
DB00993Azathioprine3Terminated2
DB01014Balsalazide3Completed2
DB01222Budesonide3Completed4
DB01222Budesonide3Recruiting1
DB01164Calcium Chloride3Completed1
DB11121Chloroxylenol3Not Yet Recruiting1
DB00169Cholecalciferol3Not Yet Recruiting1
DB12189Etrolizumab3Active Not Recruiting2
DB12189Etrolizumab3Recruiting3
DB08917Ferric carboxymaltose3Completed1
DB06674Golimumab3Completed2
DB06674Golimumab3Recruiting1
DB09106Hydroxyethyl Starch3Completed1
DB00065Infliximab3Active Not Recruiting1
DB00065Infliximab3Completed4
DB00065Infliximab3Recruiting1
DB00065Infliximab3Terminated2
DB09146Iron saccharate3Completed1
DB04398Lactic Acid3Completed1
DB00836Loperamide3Terminated1
DB01033Mercaptopurine3Recruiting1
DB00244Mesalazine3Completed23
DB06396Mesalazine3Completed2
DB00244Mesalazine3Recruiting6
DB00244Mesalazine3Terminated2
DB12612Ozanimod3Recruiting2
DB00761Potassium chloride3Completed1
DB00860Prednisolone3Completed1
DB00860Prednisolone3Terminated1
DB00635Prednisone3Recruiting1
DB14762Risankizumab3Recruiting1
DB09153Sodium chloride3Completed1
DB00864Tacrolimus3Completed2
DB00864Tacrolimus3Recruiting1
DB05298Tetomilast3Completed3
DB01041Thalidomide3Completed1
DB08895Tofacitinib3Active Not Recruiting1
DB08895Tofacitinib3Completed3
DB05679Ustekinumab3Active Not Recruiting1
DB09033Vedolizumab3Completed5
DB09033Vedolizumab3Recruiting2
DB00051Adalimumab4Active Not Recruiting1
DB00051Adalimumab4Not Yet Recruiting1
DB00993Azathioprine4Recruiting3
DB04115Berberine4Not Yet Recruiting1
DB00201Caffeine4Recruiting1
DB11121Chloroxylenol4Recruiting1
DB00537Ciprofloxacin4Completed1
DB00537Ciprofloxacin4Recruiting1
DB00514Dextromethorphan4Recruiting1
DB00898Ethanol4Completed1
DB00996Gabapentin4Terminated1
DB06674Golimumab4Completed2
DB06674Golimumab4Not Yet Recruiting1
DB06674Golimumab4Recruiting2
DB06674Golimumab4Unknown Status1
DB00741Hydrocortisone4Recruiting2
DB00065Infliximab4Completed3
DB00065Infliximab4Not Yet Recruiting2
DB00065Infliximab4Recruiting3
DB01592Iron4Completed1
DB08890Linaclotide4Completed1
DB00678Losartan4Recruiting1
DB00244Mesalazine4Completed5
DB00244Mesalazine4Recruiting1
DB00563Methotrexate4Active Not Recruiting1
DB00959Methylprednisolone4Recruiting2
DB00916Metronidazole4Recruiting1
DB00683Midazolam4Recruiting1
DB00338Omeprazole4Recruiting1
DB00085Pancrelipase4Completed1
DB00860Prednisolone4Recruiting1
DB00635Prednisone4Completed1
DB00635Prednisone4Recruiting1
DB09484Sodium fluorophosphate4Not Yet Recruiting1
DB08895Tofacitinib4Recruiting1
DB13924Varicella Zoster Vaccine (Recombinant)4Recruiting1
DB09033Vedolizumab4Active Not Recruiting1
DB09033Vedolizumab4Completed1
DB09033Vedolizumab4Not Yet Recruiting1
DB09033Vedolizumab4Recruiting5
DB00051AdalimumabNot AvailableCompleted2
DB00051AdalimumabNot AvailableRecruiting1
DB01060AmoxicillinNot AvailableTerminated1
DB00126Ascorbic acidNot AvailableCompleted1
DB10621Atlantic salmonNot AvailableCompleted1
DB00993AzathioprineNot AvailableCompleted1
DB00993AzathioprineNot AvailableRecruiting1
DB01014BalsalazideNot AvailableCompleted2
DB01222BudesonideNot AvailableCompleted1
DB01112CefuroximeNot AvailableCompleted1
DB00169CholecalciferolNot AvailableWithdrawn1
DB00537CiprofloxacinNot AvailableCompleted1
DB01211ClarithromycinNot AvailableCompleted1
DB00254DoxycyclineNot AvailableCompleted1
DB00254DoxycyclineNot AvailableTerminated1
DB06674GolimumabNot AvailableRecruiting1
DB00065InfliximabNot AvailableActive Not Recruiting3
DB00065InfliximabNot AvailableCompleted4
DB00065InfliximabNot AvailableRecruiting4
DB14009Medical CannabisNot AvailableRecruiting1
DB00244MesalazineNot AvailableCompleted2
DB00244MesalazineNot AvailableRecruiting2
DB00244MesalazineNot AvailableTerminated1
DB00563MethotrexateNot AvailableRecruiting1
DB14644Methylprednisolone hemisuccinateNot AvailableRecruiting1
DB00916MetronidazoleNot AvailableCompleted1
DB00916MetronidazoleNot AvailableTerminated1
DB00994NeomycinNot AvailableCompleted1
DB09287Polyethylene glycolNot AvailableCompleted1
DB01220RifaximinNot AvailableCompleted1
DB10565Salmon, unspecifiedNot AvailableCompleted1
DB00512VancomycinNot AvailableCompleted1
DB09033VedolizumabNot AvailableNot Yet Recruiting1
DB09033VedolizumabNot AvailableRecruiting5